Evidence map›Paper›PMID 41873409›Full record

ArticleOpen forum infectious diseases2026

Implementation of an Early Transition to Oral Antibiotics for Patients With Nonstaphylococcal Bacteremia via Real-Time Stewardship Intervention.

Tyler Tate, Brandon J Smith, J Alex Viehman, Ryan K Shields

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tyler TateDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0009-0007-2766-6995
Brandon J SmithDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
J Alex ViehmanDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Ryan K ShieldsDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-9794-5665

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral antibiotics are effective in treating uncomplicated bloodstream infections (BSIs), but they are underused. The objective of this study was to evaluate the impact of a standardized antimicrobial stewardship intervention for early transition to oral antibiotics ("oral transition") for patients with uncomplicated BSIs. Methods: A quasi-experimental study was conducted before and after implementation of a standardized stewardship intervention for patients with uncomplicated non-staphylococcal BSI over a 4-month period. Rates of oral transition and clinical outcomes were compared before and after intervention. The primary outcome was the rate of oral transition. Clinical failure (relapsed bacteremia, infection-attributable death, or new deep-seated infection with the same BSI organism) was a secondary outcome. Results: A total of 187 and 177 BSIs were evaluated before and after the intervention, respectively. Overall, 44% (82 of 187) and 43% (76 of 177) met pre-specified criteria for oral transition. Overall oral transition rates increased from 59% (48 of 82) before to 93% (71 of 76) after intervention ( Conclusions: The implementation of a real-time antimicrobial stewardship intervention resulted in an increased rate of transition to oral antibiotics and fewer overall days of therapy, without an observed difference in clinical or safety outcomes.

Indexed as

bacteremiaoral antibioticsstewardship

Identifiers

PMID41873409
PMCPMC13006138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.